Stockscreener 앱 받기
1.33
5.56%
0.07
Climb Bio Inc 주식(CLYM)의 최신 뉴스
Climb Bio appoints new chief medical officer and finance executive By Investing.com - Investing.com South Africa
Climb Bio appoints Cindy Driscoll as SVP Finance and principal financial officer - Investing.com
Climb Bio Appoints Edgar Charles as Chief Medical Officer and Cindy Driscoll as Senior Vice President, Finance - citybiz
Bristol Myers Squibb (BMY) Loses Key Executive to Climb Bio | BM - GuruFocus
Climb Bio Appoints Cindy Driscoll as Finance VP - TipRanks
Climb Bio appoints new chief medical officer and finance executive - Investing.com
Climb Bio Appoints Edgar D. Charles, M.D., MSc as Chief Medical Officer - Bluefield Daily Telegraph
Bristol Myers Squibb Immunology Leader Joins Climb Bio to Advance Breakthrough Autoimmune Programs - Stock Titan
UroGen continues to climb after bladder cancer drug approval - Seeking Alpha
Honda CR-V e:FCEV to Challenge Pikes Peak Hill Climb as First-Ever Hydrogen Powered Race Entry - Honda Newsroom
Metsera shares climb on early data for amylin-targeting obesity shot - BioPharma Dive
Head to Head Contrast: Monopar Therapeutics (NASDAQ:MNPR) vs. Climb Bio (NASDAQ:CLYM) - Defense World
Lyra Therapeutics, Inc. (NASDAQ:LYRA) Shares Sold by Two Sigma Advisers LP - Defense World
Climb Bio (NASDAQ:CLYM) Coverage Initiated at Oppenheimer - Defense World
Biotech Finishes Week Strong On Bullish Analyst Outlook - MSN
Public Employees Retirement System of Ohio Acquires 1,768 Shares of Nu Skin Enterprises, Inc. (NYSE:NUS) - Defense World
Oppenheimer Initiates Coverage of Climb Bio (CLYM) with Outperform Recommendation - Nasdaq
Circle Internet Group Stock Keeps Climbing After Big Debut - Investopedia
Oppenheimer initiates coverage on Climb Bio stock with outperform rating - Investing.com
Krill Oil Market Expected to Climb to US$ 333.2 Mn by 2032Persistence Market Research - openPR.com
Oppenheimer initiates coverage on Climb Bio stock with outperform rating By Investing.com - Investing.com UK
Oppenheimer Initiates Climb Bio at Outperform With $10 Price Target - MarketScreener
Climb Bio Elects New Board Members at Annual Meeting - TipRanks
Stocks Climb on Hopes of Easing US-China Trade Tensions - The Globe and Mail
BNP Paribas Financial Markets Has $69,000 Stock Holdings in Climb Global Solutions, Inc. (NASDAQ:CLMB) - Defense World
This stealth AI supplier just leapfrogged 206 companies on the Fortune 500 - Fortune
NIO EV Deliveries Surge 34.7% in 2025, May Numbers Show Strong Multi-Brand Growth - Stock Titan
Nuveen Asset Management LLC Acquires 53,376 Shares of Innodata Inc. (NASDAQ:INOD) - Defense World
Climb Bio (NASDAQ:CLYM) Upgraded at BTIG Research - Defense World
Are Wall Street Analysts Predicting Agilent Technologies Stock Will Climb or Sink? - MSN
Climb Bio Appoints Interim CFO Amid Leadership Change - TipRanks
BTIG sets Climb Bio stock Buy rating, $7 target By Investing.com - Investing.com Nigeria
BTIG sets Climb Bio stock Buy rating, $7 target - Investing.com
BioArctic shares climb on Q1 profit beat, boosted by Bristol payment - Investing.com Canada
Strong week for Access Bio (KOSDAQ:950130) shareholders doesn't alleviate pain of three-year loss - simplywall.st
Climb Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
What is Leerink Partnrs’ Estimate for Climb Bio Q2 Earnings? - Defense World
Climb Bio Awards $152K Stock Package to New Executive: Inside the Biotech's Latest Talent Investment - Stock Titan
Mercer Global Advisors Inc. ADV Sells 340 Shares of Atlantic Union Bankshares Co. (NASDAQ:AUB) - Defense World
Climb Bio Reports Increased Losses Amid Ongoing Development - TipRanks
Amazon.com, Inc. (NASDAQ:AMZN) Shares Sold by Capital Research Global Investors - Defense World
Climb Bio Reports First Quarter 2025 Financial Results and Provides Business Updates - The Manila Times
Tilray Brands Announces the Launch of XMG Atomic Sours: New THC Beverages and Edibles - The Manila Times
Climb Bio reports Q1 EPS (31c) vs (6c) last year - TipRanks
Climb Bio, Inc. SEC 10-Q Report - TradingView
Climb Bio (CLYM) Expected to Announce Earnings on Wednesday - Defense World
Life sciences firms climb after US and China agree to cut tariffs - TradingView
Sector Update: Health Care Stocks Climb Monday Afternoon - marketscreener.com
S&P 500 Gains & Losses Today: Index Pulls Back Early Climb Amid Anticipation of Trade Talks - Investopedia
Exec Edge Launches Research Coverage with Initiation Notes on FL - GuruFocus
Exec Edge Launches Research Coverage with Initiation Notes on FLD, CLYM, STKS, REX, ACB - Quantisnow
Market Update: Climb Bio Inc (CLYM) Sees Positive Movement, Closing at 1.21 - DWinneX
Stock Index Futures Climb on U.S.-China Trade Talk Optimism, Fed Rate Decision in Focus - The Globe and Mail
Astaxanthin Market Size to Climb USD 6.86 Billion by 2034 - Precedence Research
Dollar Falls and Gold Prices Climb on US Trade Uncertainty - The Globe and Mail
Jim Cramer on Netflix, Inc. (NFLX): ‘I Bet This One Can Continue to Climb Over the Long Haul’ - Yahoo Finance
Sugar Prices Slump on Expectations for Robust Global Supplies - The Globe and Mail
0.34%
7.69%
자본화:
|
볼륨(24시간):